Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Discover Vision Centers

Neither a doctor nor a teaching hospital

Research payments

$353,026

32 payments

Through program year 2025, Discover Vision Centers is reported as receiving $353,026 in research payments, across 32 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $9,491 4
2024 Research $19,800 5
2023 Research $52,400 6
2022 Research $18,404 4
2020 Research $248,132 11
2019 Research $4,800 2

Breakdown

Who paid Research payments · program years 2019–2025
  1. Carl Zeiss Meditec, Inc. $248,132 11 payments
  2. RxSight Inc $75,700 12 payments
  3. AbbVie, Inc. $14,904 3 payments
  4. ANI Pharmaceuticals, Inc. $9,491 4 payments
  5. Alimera Sciences, Inc. $4,800 2 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $44,174 1 payment
  2. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $43,438 1 payment
  3. Pmcs-006 $37,950 5 payments
  4. Pmcs-007 $34,250 6 payments
  5. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $26,720 1 payment
  6. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $26,312 1 payment
  7. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $21,420 1 payment
  8. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $21,058 1 payment
  9. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $18,500 1 payment
  10. A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina $14,904 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record